Utama › Myasthenia Gravis
Kajian klinikal Myasthenia Gravis sedang mengambil peserta di AS
45 kajian untuk Myasthenia Gravis sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Tampa, FL12 kajian
- Houston, TX11 kajian
- Durham, NC10 kajian
- Boca Raton, FL10 kajian
- Columbus, OH8 kajian
- Milwaukee, WI7 kajian
- St. Louis, MO7 kajian
- Miami, FL7 kajian
- New York City, NY7 kajian
- Philadelphia, PA6 kajian
- Columbia, MO6 kajian
- Jacksonville, FL6 kajian
- Washington, DC6 kajian
- Chattanooga, TN6 kajian
- Orange, CA6 kajian
- Dallas, TX6 kajian
- Boston, MA6 kajian
- Austin, TX6 kajian
- Charleston, SC6 kajian
- Kansas City, KS6 kajian
- San Francisco, CA6 kajian
- Portland, OR6 kajian
- Detroit, MI6 kajian
- Lexington, KY5 kajian
- Scottsdale, AZ5 kajian
- Cincinnati, OH5 kajian
- Port Charlotte, FL5 kajian
- Aurora, CO5 kajian
- Augusta, GA4 kajian
- New Haven, CT4 kajian
- Los Angeles, CA4 kajian
- Mountain View, CA4 kajian
- Amherst, NY4 kajian
- Chicago, IL4 kajian
- Knoxville, TN3 kajian
- Lansing, MI3 kajian
- Clearwater, FL3 kajian
- Brockton, MA3 kajian
- Indianapolis, IN3 kajian
- Phoenix, AZ3 kajian
Mengikut negeri
- Arizona7 kajian
- California20 kajian
- Colorado8 kajian
- Connecticut6 kajian
- Florida22 kajian
- Georgia4 kajian
- Illinois12 kajian
- Indiana3 kajian
- Kansas7 kajian
- Kentucky6 kajian
- Massachusetts11 kajian
- Michigan12 kajian
- Minnesota3 kajian
- Missouri7 kajian
- Nevada3 kajian
- New Jersey3 kajian
- New York13 kajian
- North Carolina14 kajian
- Ohio13 kajian
- Oregon8 kajian
- Pennsylvania6 kajian
- South Carolina7 kajian
- Tennessee10 kajian
- Texas18 kajian
- Virginia3 kajian
- Wilayah Columbia6 kajian
- Wisconsin7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07787247A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Mengambil pesertaFasa 3
Umur 18 hingga 74 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07647510ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07294170A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07465289ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07501702A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Mengambil pesertaFasa 2
Umur 2 hingga 17 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06987539Zilucoplan for Severe gMG Exacerbations
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06414954AXIS MG Patient Registry
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07761026A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07304154RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Mengambil pesertaFasa 1/2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT06359041Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Wanita · Dikemas kini 11 Ogo 2026 · NCT06940323MuSK Myasthenia 1000 Study
Mengambil pesertaKajian pemerhatian
Umur 7 hingga 99 · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06259071Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Mengambil pesertaFasa 1/2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Mengambil pesertaFasa 2/3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Mengambil pesertaFasa 2/3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06193889A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04951622Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.